Bookmark

Add to MyYahoo RSS

Novo Nordisk AS News

News on Novo Nordisk AS (Ticker: NVO) continually updated from thousands of sources around the net.

13 hrs ago | Seeking Alpha

Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?

I believe there is a good chance that ELIXA will report positive data. In such a scenario the consensus estimates for Lyxumia will increase from $450m to $2.9b.

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Insulin (generic), Humulin, Novolin

Tue Apr 15, 2014

Pharmaceutical Online

Novo Nordisk Brazil: World Market Leader In Diabetes Care Implements ...

Novo Nordisk, the world market leader in diabetes care, implemented PAS-X V3.1.5 successfully at their Brazilian site in Montes Claros.

Comment?

Related Topix: Biotech, South America, World News, Brazil, Medicine, Insulin (generic), Humulin, Novolin

Mon Apr 14, 2014

The Verona-Cedar Grove Times

Diabetes to rise even more, study finds

Approximately 52 percent of the adult population will have either diabetes or prediabetes in the year 2020, according to a study by Novo Nordisk, a Denmark-based global health care company specializing in diabetes care.

Comment?

Related Topix: Biotech

BioSpace

Novo Nordisk A/S - Share Repurchase Programme

On 30 January 2014, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Comment?

Related Topix: Biotech

Thu Apr 10, 2014

The Daily Star

Novo Nordisk launches new-generation insulin

Camilla Sylvest, extreme right, regional vice president of Novo Nordisk, attends a press briefing to announce the launch of new-generation insulin Tresiba in Bangladesh, at Radisson Hotel in Dhaka yesterday.

Comment?

Related Topix: Biotech, Medicine, Insulin (generic), Humulin, Novolin, Bangladesh, World News, Asia, Diabetes, Health

Wed Apr 09, 2014

The Daily Star

Novo Nordisk regional head arrives in Dhaka today

Camilla Sylvest, regional vice president of the world's largest Danish insulin manufacturer Novo Nordisk, is scheduled to arrive in Dhaka today for a short visit.

Comment?

Related Topix: Biotech, Bangladesh, World News, Asia, Medicine, Insulin (generic), Humulin, Novolin

Tue Apr 08, 2014

Sys-Con Media

New Model Needed in Diabetes Care

Urgent need to mobilise and involve people with diabetes in partnership efforts to face the challenges of the diabetes pandemic Participants at the 5th International DAWNa Summit today pledged to work together to make person-centred diabetes care a reality for the 382 million people living with diabetes around the world.[1] While it is widely ... (more)

Comment?

Related Topix: Medicine, Health, Diabetes, Biotech

Sys-Con Media

Upcoming Events, Shares, Stock Price Updates, Notes Exchange Offer,...

Upcoming Events, Shares, Stock Price Updates, Notes Exchange Offer, Clinical Study Results and New Product Launch - Analyst Notes on Salix, Endo, ISIS, IDEXX, and Novo Today, Analysts Review released its analysts' notes regarding Salix Pharmaceuticals, Ltd. , Endo International PLC , ISIS Pharmaceuticals, Inc. , IDEXX Laboratories, Inc. , and Novo ... (more)

Comment?

Related Topix: Biotech, Medicine, IDEXX Laboratories, Healthcare Industry, Endo Pharmaceuticals Holdings, Salix Pharmaceuticals, Isis Pharmaceuticals

Mon Apr 07, 2014

The Motley Fool

Does Biogen Idec Inc Have a New Blockbuster Hemophilia Therapy?

Will Biogen sew up the hemophilia B market only to watch it quickly unravel ? Big improvement Hemophilia B is characterized by insufficient levels of factor 9, a protein involved in the clotting process.

Comment?

Related Topix: Biotech, Biogen Idec

BioSpace

Novo Nordisk A/S - Share Repurchase Programme

On 30 January 2014, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Comment?

Related Topix: Biotech

Sat Apr 05, 2014

GhanaWeb

Two diabetes support centres established in Accra

Two diabetes support centres have been inaugurated in Accra to give diabetics access to health care and insulin.

Comment?

Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Biotech, World News, Ghana, Africa

Fri Apr 04, 2014

CSRwire.com

Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes

Novo Nordisk announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge.

Comment?

Related Topix: Biotech

Tue Apr 01, 2014

BioSpace

Status Regarding Novo Nordisk A/S's Holding Of Its Own Shares

In continuation of the company's announcements dated 31 October 2013 and 30 January 2014 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S and its wholly-owned affiliates on 31 March 2014 owned 114,201,901 of its own B shares ... (more)

Comment?

Related Topix: Biotech

BioResearch Online

Novo Nordisk Launches 'Cities Changing Diabetes' Initiative

Novo Nordisk has announced the launch of 'Cities Changing Diabetes,' an ambitious new partnership program formed to fight the challenge of urban diabetes.

Comment?

Related Topix: Biotech

Sun Mar 30, 2014

Hucknall and Bulwell Dispatch

Sherwood MP Mark Spencer raises awareness about diabetes

Sherwood MP Mark Spencer joined volunteers from the International Diabetes Federation and staff from Novo Nordisk and Roche, leaders in diabetes care, to raise awareness of the increasing prevalence of diabetes in the UK).

Comment?

Related Topix: Medicine, Health, Diabetes, Biotech

Sat Mar 29, 2014

PezCycling News

Catching Up With Martijn Verschoor

It's March so it must be time to catch up with Novo Nordisk rider; Martijn Verschoor.

Comment?

Related Topix: Biotech, us Travel, Travel, Cycling

Fri Mar 28, 2014

Canada NewsWire

Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes

The 'Cities Changing Diabetes' programme will first be launched in "The global diabetes epidemic is an emergency in slow motion," says Lars Rebien Sorensen, chief executive officer, Novo Nordisk.

Comment?

Related Topix: Biotech

Sys-Con Media

Novo Nordisk Launches 'Cities Changing Diabetes' to Fight Urban Diabetes

Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge.

Comment?

Related Topix: Biotech

Wed Mar 26, 2014

Sys-Con Media

Critical Alerts For Netflix, Novo Nordisk, L Brands, Royal Caribbean, ...

To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/32520141 Today's PriceWatch Alerts cover the following stocks: Netflix , Novo Nordisk , L Brands , Royal Caribbean , and Fusion-io .

Comment?

Related Topix: Netflix, Startups, Travel/Tourism, Biotech, Royal Caribbean Cruises

Tue Mar 25, 2014

The Motley Fool

Last Week's BioPharma R&D Winners

Good enough to quit early On Thursday, Johnson & Johnson scored a big win in a notoriously difficult field.

Comment?

Related Topix: Johnson & Johnson, Healthcare Law, Law, Biotech, Amgen

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••